Kusama H, Horimoto Y, Takabe K, Ishikawa T. Should All Low-Grade Ductal Carcinoma In Situ Be Excised? Implications and Challenges of the COMET Trial. World J Oncol [Internet]. 2025 Mar. 25 [cited 2025 Apr. 3];16(2):239-41. Available from: https://wjon.elmerpub.com/wjon/article/view/2562